Last update 01 Sep 2025

CN119638700

Patent Mining

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
FBXO22 x NSD2 x VHL x VHLL
Action
degraders
Mechanism
NSD2 degraders(nuclear receptor binding SET domain protein 2 degraders), VHL degraders(von Hippel-Lindau tumor suppressor degraders)
Therapeutic Areas
Neoplasms
Active Indication
Neoplasms
Inactive Indication-
Originator Organization
Zhong Ke Zhong Shan Yao Wu Chuang Xin Yan Jiu YuanShanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of SciHangzhou Institute for Advanced Study, UCAS
Active Organization
Shanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of SciZhong Ke Zhong Shan Yao Wu Chuang Xin Yan Jiu YuanHangzhou Institute for Advanced Study, UCAS
Inactive Organization-
License Organization-
Drug Highest PhaseDiscovery
First Approval Date-
Regulation-

Related

100 Clinical Results associated with CN119638700
Login to view more data
100 Translational Medicine associated with CN119638700
Login to view more data
100 Patents (Medical) associated with CN119638700
Login to view more data
100 Deals associated with CN119638700
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsDiscovery-
Shanghai Institute of Materia Medica Chinese Academy of SciShanghai Institute of Materia Medica Chinese Academy of Sci
18 Mar 2025
NeoplasmsDiscovery-
Zhong Ke Zhong Shan Yao Wu Chuang Xin Yan Jiu Yuan
18 Mar 2025
NeoplasmsDiscovery-
Hangzhou Institute for Advanced Study, UCAS
18 Mar 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free